SCHEMBL7841486

SCHEMBL7841486

Nc1ncnc2c1c(-c1cccc(O)c1)cn2-c1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 19/20 0.78
EGFR P00533 11/20 0.78
ABL1 P00519 9/20 0.78
ABL2 P42684 9/20 0.78
KDR P35968 6/20 0.78
CDK1 P06493 6/20 0.78
PIK3CD O00329 1/20 0.65
PIK3CA P42336 1/20 0.65
PIK3CB P42338 1/20 0.65
PIK3CG P48736 1/20 0.65
PRKDC P78527 1/20 0.65
JAK2 O60674 1/20 0.61
NTRK1 P04629 1/20 0.61
INSR P06213 1/20 0.61
LCK P06239 1/20 0.61
NPM1 P06748 1/20 0.61
CSF1R P07333 1/20 0.61
LYN P07948 1/20 0.61
RET P07949 1/20 0.61
IGF1R P08069 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843715 0.93 SRC (0.78) SRCEGFRABL1ABL2KDR
SCHEMBL5936176 0.88 SRC (1.00) SRCEGFRABL1ABL2KDR
SCHEMBL31061695 0.88 SRC (1.00) SRCEGFRABL1ABL2KDR
SCHEMBL7844427 0.86 SRC (1.00) SRCEGFRABL1ABL2KDR
SCHEMBL7845704 0.86 SRC (0.84) SRCEGFRABL1ABL2KDR
SCHEMBL7845787 0.86 SRC (0.84) SRCEGFRABL1ABL2KDR
SCHEMBL7845957 0.85 SRC (0.66) SRCEGFRABL1ABL2KDR
SCHEMBL7844402 0.84 SRC (0.75) SRCEGFRABL1ABL2KDR
SCHEMBL7844580 0.84 SRC (0.76) SRCEGFRABL1ABL2KDR
SCHEMBL7833834 0.83 SRC (0.67) SRCEGFRABL1ABL2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783505-B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2001-03-07 EP disclosed
EP-0783505-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE Novartis AG (CH) 1997-07-16 EP disclosed
WO-1996010028-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 1996-04-04 WO disclosed